NICE rebuffs Javlor

The U.K.'s NICE issued a preliminary appraisal recommending against the use of Javlor vinflunine from Laboratoires Pierre Fabre S.A. (Castres, France) in its approved indication of advanced or metastatic transitional cell carcinoma of the urothelial tract that has progressed following treatment with platinum based chemotherapy. ...